Veeva Systems Net Cash Flow 2012-2025 | VEEV

Veeva Systems net cash flow for the twelve months ending April 30, 2025 was $2.062B, a 8449.39% increase year-over-year.

  • Veeva Systems annual net cash flow for 2025 was $0.414B, a 326.41% decline from 2024.
  • Veeva Systems annual net cash flow for 2024 was $-0.183B, a 27.27% decline from 2023.
  • Veeva Systems annual net cash flow for 2023 was $-0.252B, a 161.43% decline from 2022.

Veeva Systems Net Cash Flow 2012-2025 | VEEV

  • Veeva Systems annual net cash flow for 2025 was $0.414B, a 326.41% decline from 2024.
  • Veeva Systems annual net cash flow for 2024 was $-0.183B, a 27.27% decline from 2023.
  • Veeva Systems annual net cash flow for 2023 was $-0.252B, a 161.43% decline from 2022.
Related Stocks
Company NameMarket
Cap
Tempus AI (TEM)$13.2B
Doximity (DOCS)$12.4B
Hims & Hers Health (HIMS)$9.7B
IRhythm Technologies (IRTC)$5.3B
Hinge Health (HNGE)$4.3B
Inspire Medical Systems (INSP)$2.7B
Privia Health (PRVA)$2.6B
Heartflow (HTFL)$2.4B
Phreesia (PHR)$1.8B
Enovis (ENOV)$1.8B
10x Genomics (TXG)$1.8B
Omnicell (OMCL)$1.5B
Schrodinger (SDGR)$1.4B
Azenta (AZTA)$1.4B
Clover Health Investments (CLOV)$1.4B
Claritev (CTEV)$1.2B
Evolent Health (EVH)$1.1B
Fulgent Genetics (FLGT)$659M
Zepp Health (ZEPP)$570M
Veradigm (MDRX)$525M
Standard BioTools (LAB)$474M
Talkspace (TALK)$445M
Butterfly Network (BFLY)$390M
Carlsmed (CARL)$380M
TruBridge (TBRG)$298M
Outset Medical (OM)$244M
Health Catalyst (HCAT)$235M
SOPHiA GENETICS SA (SOPH)$233M
Nyxoah SA (NYXH)$220M
KORU Medical Systems (KRMD)$194M